We are live on ! Find out more
SONN

Sonnet BioTherapeutics
SONN

Delisted

SONN was delisted on the 2nd of December, 2025.

Back to rankings

hedge funds and large institutions have $509K invested in Sonnet BioTherapeutics in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $532K → $509K (-$23K)

Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$25K
2
Citadel Advisors
Citadel Advisors
Florida
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$120K – – –
IC
2
Intersect Capital
California
$68K – – –
BIT
3
BlackRock Institutional Trust
California
$56K – – –
EVC
4
Eidelman Virant Capital
Missouri
$53K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$50K – – –
GHAM
6
Gilman Hill Asset Management
Connecticut
$33K – – –
Bank of America
7
Bank of America
North Carolina
$24K – – –
CDH
8
Charles D. Hyman
$24K – – –
TDC
9
Thompson Davis & Co
Virginia
$17K – – –
SI
10
SII Investments
Wisconsin
$16K – – –
VKH
11
Virtu KCG Holdings
New York
$15K – – –
CL
12
CSS LLC
Illinois
$12K – – –
Northern Trust
13
Northern Trust
Illinois
$10K – – –
BFA
14
BlackRock Fund Advisors
California
$4K – – –
First Manhattan
15
First Manhattan
New York
$4K – – –
Barclays
16
Barclays
United Kingdom
$2K – – –
IA
17
IFP Advisors
Florida
$1K – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$15K – –
Stifel Financial
19
Stifel Financial
Missouri
– -$25K – –